Lee Howard 4
4 · Amphastar Pharmaceuticals, Inc. · Filed Jun 7, 2022
Insider Transaction Report
Form 4
Lee Howard
Director
Transactions
- Exercise/Conversion
Common Stock
2022-06-06$17.11/sh+10,291$176,079→ 149,067 total - Sale
Common Stock
2022-06-06$37.79/sh−10,291$388,859→ 138,776 total - Exercise/Conversion
Stock Option (right to buy)
2022-06-06−10,291→ 0 totalExercise: $17.11Exp: 2022-06-08→ Common Stock (10,291 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.425 to $38.21, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F2]Shares subject to the option are fully vested and immediately exercisable.